Related Experiment Video
Updated: Aug 15, 2026

16:27
Strategies for Study of Neuroprotection from Cold-preconditioning
Published on: September 2, 2010
Interventions with neuroprotective agents: novel targets and opportunities
1Spinal Cord and Brain Injury Research Center, Department of Anatomy and Neurobiology, University of Kentucky, Lexington, KY, USA. PatSull@uky.edu
Epilepsy & Behavior : E&B
|October 22, 2005
Summary
Antiepileptic drugs may protect brain cells by targeting mitochondrial dysfunction. These drugs inhibit excitotoxicity, a process linked to neuronal cell death during seizures.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Neurodegeneration in epilepsy involves excitotoxicity.
- Mitochondria play a key role in energy metabolism and apoptosis.
- Mitochondrial dysfunction is implicated in seizure-induced neuronal death.
Purpose of the Study:
- To explore the neuroprotective mechanisms of antiepileptic drugs.
- To investigate the role of mitochondria in epilepsy-related neurodegeneration.
- To identify mitochondrial Ca(2+) homeostasis as a therapeutic target.
Main Methods:
- Review of existing literature on antiepileptic drugs and neuroprotection.
- Analysis of the role of excitotoxicity in mitochondrial dysfunction.
- Examination of the impact of cytosolic Ca(2+) on mitochondrial function.
Main Results:
- Antiepileptic drugs show neuroprotective effects in animal models.
- Inhibition of excitotoxic cascade components is a key mechanism.
- Mitochondrial dysfunction, driven by Ca(2+) overload, contributes to neuronal death.
Conclusions:
- Mitochondrial dysfunction is central to epilepsy-associated neurodegeneration.
- Antiepileptic drugs may exert neuroprotection by stabilizing mitochondrial function.
- Targeting Ca(2+)-mediated mitochondrial dysfunction is a promising therapeutic strategy for epilepsy.
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...